A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the ...

At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to help the ...

MicroPort CardioFlow Medtech Corp. ( ($HK:2160) ) just unveiled an update. MicroPort CardioFlow Medtech Corporation announced the formal release ...

What Is Mitral Valve Regurgitation? When your heart pumps blood, it’s supposed to follow a specific path in one direction. But sometimes, it goes the wrong way. Mitral valve regurgitation is when your ...

Mitral valve stenosis, also known as mitral stenosis, occurs when the mitral valve opening is narrowed. This means that not enough blood can flow through it. Scarring caused by rheumatic fever is the ...

Mitral valve disease occurs when the mitral valve doesn’t work properly, allowing blood to flow backward into the left atrium. As a result, your heart does not pump enough blood out of the left ...

Medical device startup CardioMech announced this week that it has raised $13 million in new capital, bringing its total funding to $42 million. With the fresh funds, the company hopes to advance the ...

The SAPIEN M3 system received CE Mark in April 2025, making it the world’s first approved transfemoral transcatheter mitral ...

At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to help the ...